Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:627-632
doi: 10.1161/hc0502.102965
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marin-Castaño, M. E.
Right arrow Articles by Bascands, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marin-Castaño, M. E.
Right arrow Articles by Bascands, J.-L.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Hypertension - basic studies

(Circulation. 2002;105:627.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Induction of Functional Bradykinin B1-Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor Treatment

Maria E. Marin-Castaño, PhD*; Joost P. Schanstra, PhD*; Eric Neau; Françoise Praddaude, PhD; Christiane Pecher; Jean-Louis Ader, MD; Jean-Pierre Girolami, PhD; Jean-Loup Bascands, PhD

From the Institut National de la Santé et de la Recherche Médicale INSERM U 388, Institut Louis Bugnard, CHU Rangueil, Toulouse, France.

Correspondence to J.P. Girolami, INSERM U388, Institut Louis Bugnard, CHU Rangueil, 31403 Toulouse Cedex, France. E-mail girolami{at}toulouse.inserm.fr

Background The physiological effects of ACE inhibitors may act in part through a kinin-dependent mechanism. We investigated the effect of chronic ACE-inhibitor treatment on functional kinin B1- and B2-receptor expression, which are the molecular entities responsible for the biological effects of kinins.

Methods and Results Rats were subjected to different 6-week treatments using various mixtures of the following agents: ACE inhibitor, angiotensin AT1-receptor antagonist, and B1- and B2-receptor antagonists. Chronic ACE inhibition induced both renal and vascular B1-receptor expression, whereas B2-receptor expression was not modified. Furthermore, with B1-receptor antagonists, it was shown that B1-receptor induction was involved in the hypotensive effect of ACE inhibition. Using microdissection, we prepared 10 different nephron segments and found ACE-inhibitor–induced expression of functional B1-receptors in all segments. ACE-inhibitor–induced B1-receptor induction involved homologous upregulation, because it was prevented by B1-receptor antagonist treatment. Finally, using B2-receptor knockout mice, we showed that ACE-inhibitor–induced B1-receptor expression was B2-receptor independent.

Conclusions This study provides the first evidence that chronic ACE-inhibitor administration is associated with functional vascular and renal B1-receptor induction, which is involved in ACE-inhibitor–induced hypotension. The observed B1-receptor induction in the kidney might participate in the known renoprotective effects of ACE inhibition.


Key Words: angiotensin-converting enzyme • bradykinin • kidney • blood pressure




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.-P. Girolami
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1083 - F1092.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. E. Moreau, P. Dubreuil, G. Molinaro, M. Chagnon, W. Muller-Esterl, Y. Lepage, F. Marceau, and A. Adam
Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1065 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. J. Oliver, D. J. Webb, and D. E. Newby
Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2470 - 2479.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Picard, M. Van Abel, C. Campone, M. Seiler, M. Bloch-Faure, J. G.J. Hoenderop, J. Loffing, P. Meneton, R. J.M. Bindels, M. Paillard, et al.
Tissue Kallikrein-Deficient Mice Display a Defect in Renal Tubular Calcium Absorption
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3602 - 3610.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-P. Fortin, L. Gera, J. Bouthillier, J. M. Stewart, A. Adam, and F. Marceau
Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1169 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. M. Tiwari, P. L. Prather, and P. R. Mayeux
Mechanism of Bradykinin-Induced Ca2+ Mobilization in Murine Proximal Tubule Epithelial Cells
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Liesmaa, A. Kuoppala, N. Shiota, J. O. Kokkonen, K. Kostner, M. Mayranpaa, P. T. Kovanen, and K. A. Lindstedt
Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2317 - H2322.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. L.M. Cruden, G. H. Tse, K. A.A. Fox, C. A. Ludlam, I. Megson, and D. E. Newby
B1 Kinin Receptor Does Not Contribute to Vascular Tone or Tissue Plasminogen Activator Release in the Peripheral Circulation of Patients With Heart Failure
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 772 - 777.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. L.M. Cruden, K. A.A. Fox, C. A. Ludlam, N. R. Johnston, and D. E. Newby
Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition
Hypertension, December 1, 2004; 44(6): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Ignjatovic, S. Stanisavljevic, V. Brovkovych, R. A. Skidgel, and E. G. Erdos
Kinin B1 Receptors Stimulate Nitric Oxide Production in Endothelial Cells: Signaling Pathways Activated by Angiotensin I-Converting Enzyme Inhibitors and Peptide Ligands
Mol. Pharmacol., November 1, 2004; 66(5): 1310 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. C. Sulpizio, M. A. Pullen, R. M. Edwards, and D. P. Brooks
The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. L.M. Cruden, F. N. Witherow, D. J. Webb, K. A.A. Fox, and D. E. Newby
Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1043 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Tschope, F. Spillmann, C. Altmann, M. Koch, D. Westermann, N. Dhayat, S. Dhayat, J.-L. Bascands, L. Gera, S. Hoffmann, et al.
The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction
Cardiovasc Res, February 15, 2004; 61(3): 559 - 569.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Schmaier
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.N. Dzeka, R. Townley, and J.M. O. Arnold
Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins
Cardiovasc Res, July 1, 2003; 59(1): 250 - 256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. A. Skidgel, F. Alhenc-Gelas, and W. B. Campbell
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Prologue: Kinins and related systems. New life for old discoveries
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1886 - H1891.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Ongali, H. d. S. Buck, F. Cloutier, F. Legault, D. Regoli, C. Lambert, G. Thibault, and R. Couture
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1949 - H1958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sangsree, V. Brovkovych, R. D. Minshall, and R. A. Skidgel
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1959 - H1968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Molinaro, M. Cugno, M. Perez, Y. Lepage, N. Gervais, A. Agostoni, and A. Adam
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 232 - 237.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. N. Witherow, P. Dawson, C. A. Ludlam, K. A. A. Fox, and D. E. Newby
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 961 - 966.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Trabold, S. Pons, A. A. Hagege, M. Bloch-Faure, F. Alhenc-Gelas, J.-F. Giudicelli, C. Richer-Giudicelli, and P. Meneton
Cardiovascular Phenotypes of Kinin B2 Receptor- and Tissue Kallikrein-Deficient Mice
Hypertension, July 1, 2002; 40(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ignjatovic, F. Tan, V. Brovkovych, R. A. Skidgel, and E. G. Erdos
Novel Mode of Action of Angiotensin I Converting Enzyme Inhibitors. DIRECT ACTIVATION OF BRADYKININ B1 RECEPTOR
J. Biol. Chem., May 3, 2002; 277(19): 16847 - 16852.
[Abstract] [Full Text] [PDF]